Fed Circuit orders new Bio-Rad trial, but upholds $24m award

04-08-2020

Muireann Bolger

Fed Circuit orders new Bio-Rad trial, but upholds $24m award

Bill Perry / Shutterstock.com

The US Court of Appeals for the Federal Circuit has partially lifted an injunction on 10X Genomics, but the biotech company must still pay almost $24 million for infringing a Bio-Rad patent.


Bio-Rad, 10X Genomics, Federal Circuit, labs-on-a-chip, damages, patent infringement, Delaware, district court, appeal

LSIPR